Recombinant Human Epidermal Growth Factor
Description
Recombinant Human Epidermal Growth Factor is used for the faster healing of diabetic foot ulcers in patients with diabetes and helps to prevent the amputation (a process of surgical removal of all or part of body extremity) in such patients. The lower strength of this medicine is used for first and second-degree burns, skin grafts and also in the management of bedsores.
QUICK LINKS:
Side effects
Major & minor side effects for Recombinant Human Epidermal Growth Factor
- Redness of skin
- Skin Rash
- Skin discoloration
- Skin irritation
- Skin burning sensation
- Dry skin
Uses of Recombinant Human Epidermal Growth Factor
What is it prescribed for?
- Diabetic foot ulcers
- Other uses
Read More
Concerns
Commonly asked questions
- Onset of actionThe amount of time required for this medicine to show its action is not clinically established.
- Duration of effectThe amount of time for which this medicine remains active in the body is not clinically established.
- Safe with alcohol?Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
- Is it habit forming?No habit-forming tendencies were reported.
- Usage in pregnancy?This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
- Usage while breast-feeding?This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
Allergy
This medicine is not recommended for use in patients with a known allergy to Recombinant Human Epidermal Growth Factor or any other inactive ingredients present along with it.
Immune compromised patients
This medicine is not recommended for use in immune-compromised patients or who receives immune stimulant or suppressive treatments.
Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
General warnings
Other medicines
Recombinant Human Epidermal Growth Factor is known to interact with a large number of medications you might possibly be taking. It is recommended to report the use of all medicines including herbs and supplements to the doctor to ensure safe and effective use.
External use only
This medicine is meant for external use only. Avoid contact with eyes, nose, and mouth.
Missed Dose
Apply the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not apply a double dose to make up for the missed one.
Overdose
An overdose of this medicine is not likely to cause severe symptoms. However, ingestion of this medicine may cause harm and immediate medical intervention may be required.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Instructions
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Disease interactions
Disease
Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Apply a thin layer of the gel to the affected area as instructed by the doctor. Follow all the usage instructions mentioned on the label or the package insert. Do not apply in larger or smaller quantities than recommended. Do not cover the application area with bandages or other coverings unless specifically instructed by the doctor.
Miscelleneous
How it works
This medicine fastens the wound healing process by stimulating skin regeneration.
Legal Status
Classification
Category
Epidermal Growth Factor , Topical agents
Schedule
Schedule H
[Internet]. Bharatbiotech.com. 2019 [cited 6 June 2019]. Available from:
Nepidermin - DrugBank [Internet]. Drugbank.ca. 2019 [cited 8 January 2019]. Available from:
Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2019 [cited 6 June 2019]. Available from:
Information on this page was last updated on 15 Apr 2020
Disclaimer
We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.